Literature DB >> 580734

Effect of selenium on the organ distribution and binding of bismuth in rat tissues.

J A Szymańska, M Zychowicz, A J Zelazowski, J K Piotrowski.   

Abstract

Subcutaneous administration of bismuth, both single and multiple, resulted in deposition of this metal mainly in the kidneys which contained over 50% of the 'accessible pool' of bismuth. In the kidneys bismuth was bound mainly by the soluble fraction in which it was complexed with a protein of molecular weight of about 7000. Multiple administration of bismuth increased the level of this protein. Selenite administration brought about an increase in the 'accessible pool' of bismuth, probably due to a drop in excretion, and also changes in the organ distribution of this metal. The retention in the kidneys was diminished while those in the liver and in other tissues were augmented. These changes were accompanied by a change in the chemical form of bismuth present in the kidneys manifested by the total disappearance of the protein complex of molecular weight of 7000. The increased synthesis of this protein due to bismuth administration was not abolished completely.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 580734     DOI: 10.1007/bf01891968

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

1.  Metabolic studies with radiobismuth. I. Retention and distribution of 206Bi in the normal rat.

Authors:  G A Russ; R E Bigler; R S Tilbury; H Q Woodard; J S Laughlin
Journal:  Radiat Res       Date:  1975-09       Impact factor: 2.841

2.  Selenium - induced redistribution of cadmium binding to tissue proteins: a possible mechanism of protection against cadmium toxicity.

Authors:  R W Chen; P D Whanger; P H Weswig
Journal:  Bioinorg Chem       Date:  1975-01

3.  The influence of selenium on binding of inorganic mercury by metallothionein in the kidney and liver of the rat.

Authors:  E Kosta-Szumska; J Chmielnicka; J K Piotrowski
Journal:  Biochem Pharmacol       Date:  1976-11-15       Impact factor: 5.858

4.  A modified procedure for determination of metallothionein-like proteins in animal tissues.

Authors:  A J Zelazowski; J K Piotrowski
Journal:  Acta Biochim Pol       Date:  1977       Impact factor: 2.149

5.  Intracellular distribution of inorganic and organic mercury in rat liver after exposure to methylmercury salts.

Authors:  T Norseth; M Brendeford
Journal:  Biochem Pharmacol       Date:  1971-06       Impact factor: 5.858

6.  Selenite-induced binding of inorganic mercury in blood and other tissues in the rat.

Authors:  A E Moffitt; J J Clary
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-03

7.  Binding of bismuth in the kidneys of the rat: the role of metallothionein-like proteins.

Authors:  J A Szymanska; E M Mogilnicka; B W Kaszper
Journal:  Biochem Pharmacol       Date:  1977-02-01       Impact factor: 5.858

8.  Influence of certain metals on the level of metallothionein-like proteins in the liver and kidneys of rats.

Authors:  J K Piotrowski; J A Szymańska
Journal:  J Toxicol Environ Health       Date:  1976-07

9.  Binding of mercury and selenium in subcellular fractions of rat liver and kidneys following separate and joint administration.

Authors:  E Komsta-Szumska; J Chmielnicka
Journal:  Arch Toxicol       Date:  1977-09-28       Impact factor: 5.153

10.  Mercury binding in the kidney and liver of rats repeatedly exposed to mercuric chloride: induction of metallothionein by mercury and cadmium.

Authors:  J K Piotrowski; B Trojanowska; J M Wiśniewska-Knypl; W Bolanowska
Journal:  Toxicol Appl Pharmacol       Date:  1974-01       Impact factor: 4.219

View more
  2 in total

1.  Distribution of tin in the rat and disturbances in the metabolism of zinc and copper due to repeated exposure to SnCl2.

Authors:  J Chmielnicka; J A Szymańska; J Snieć
Journal:  Arch Toxicol       Date:  1981-07       Impact factor: 5.153

Review 2.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.